You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Cancer
  5. Ovarian cancer

Niraparib for maintenance treatment of relapsed, platinum-sensitive ovarian, fallopian tube and peritoneal cancer

  • Technology appraisal guidance
  • Reference number: TA784
  • Published:  20 April 2022
  • Guidance
  • Tools and resources
  • Information for the public
  • Evidence
  • History

Evidence

Review and download supporting evidence. Includes the full guideline if available.

Supporting evidence

  • Evaluation report

  • Appraisal consultation committee papers (TA784) (PDF 5.96 MB)

    Published:
    20 April 2022
  • Final appraisal determination committee papers (TA784) (PDF 3.61 MB)

    Published:
    20 April 2022
  • Appraisal consultation committee papers (TA528) (PDF 12.45 MB)

    Published:
    04 July 2018
  • Final appraisal consultation determination committee papers (TA528)  (PDF 3.53 MB)

    Published:
    04 July 2018
Back to top